IPO - Marpai, Inc.
Form Type: S-1
Filing Date: 2024-12-23
Corporate Action: Ipo
Type: New
Accession Number: 000121390024111913
Filing Summary: Marpai, Inc., a technology platform company specializing in third-party administration of healthcare benefits using AI and data analytics, filed a Registration Statement on Form S-1 with the SEC. This registration pertains to the sale of up to 5,705,996 shares of its common stock by selling stockholders, issued under securities purchase agreements dated August 28 and December 5, 2024. The company emphasizes its mission to lower healthcare costs for self-insured employers and improve health outcomes for their employees. The document discusses various risk factors associated with the investment, including substantial doubt about the company's ability to continue as a going concern due to accumulated losses and reliance on a major customer. The last reported sale price of Marpai's common stock was $0.98 as of December 20, 2024. Key financial information indicates a significant accumulated deficit and the need for future capital raising efforts to sustain operations and growth.
Document Link: View Document
Additional details:
Common Stock Offered: 5,705,996
Common Stock Outstanding Prior To Offering: 14,361,686
Use Of Proceeds: The issuer will not receive any proceeds from the sale of the common stock by the Selling Stockholders.
Otc Market Symbol: MRAI
Last Reported Sale Price: 0.98
Reporting Period Ending: 2023-12-31
Accumulated Deficit: 76.7 million
Long Term Debt: 19.4 million
Short Term Debt: 0.6 million
Unrestricted Cash: 1.1 million
Net Loss 2023: 28.8 million
Cash Flows Negative: 15.7 million
Customer Concentration Risk: One major customer accounted for a significant portion of total revenue.
Company Address: 615 Channelside Drive, Suite 207, Tampa, Florida 33602
Comments
No comments yet. Be the first to comment!